Caffeine

Caffeine
Vaccinationist · Public domain · source
Name	Caffeine
Caption	Structural formula of caffeine
Other names	1,3,7-trimethylxanthine
Formula	C8H10N4O2
Molar mass	194.19 g·mol−1
Density	1.23 g·cm−3
Melting point	235–238 °C
Solubility	2 g·L−1 (25 °C, water)

Caffeine is a naturally occurring xanthine alkaloid found in the seeds, leaves, and fruits of several plants such as Coffea arabica, Camellia sinensis, and Paullinia cupana. It is widely consumed worldwide in beverages and foods produced by companies like Nestlé, Keurig Dr Pepper, and Starbucks Corporation, and plays roles in industries represented by organizations such as the International Coffee Organization and the World Health Organization. Known for its stimulant effects, it has been studied in contexts including Nobel Prize-winning research on neurotransmission, clinical trials at institutions like Mayo Clinic and Johns Hopkins University, and public health policy discussions in forums such as the Centers for Disease Control and Prevention.

Chemistry and sources

Caffeine is an alkaloid in the methylxanthine class related to compounds studied by chemists at Royal Society of Chemistry and synthesized in laboratories of researchers like Friedrich Sertürner and Adolf von Baeyer. Its molecular structure (C8H10N4O2) contains fused imidazole and pyrimidine rings analogous to purines investigated by scientists at Max Planck Society and Cold Spring Harbor Laboratory. Natural sources include beans and leaves harvested in regions such as Ethiopia, Brazil, China, and India and processed by companies like Lavazza and Tata Group. Botanical taxa producing methylxanthines include genera like Coffea, Camellia, Theobroma, and Paullinia, with varieties such as Coffea canephora and Camellia sinensis var. assamica used by producers such as Twinings and Illy. Synthetic production methods trace to organic chemistry work at universities including Harvard University and University of Oxford.

Pharmacology and mechanisms of action

Caffeine acts primarily as a nonselective antagonist at adenosine receptors (A1, A2A) characterized in receptor mapping studies at National Institutes of Health and Salk Institute. It modulates neurotransmitter systems including dopamine pathways explored in research from Columbia University and University College London, and influences catecholamines measured in trials at Cleveland Clinic. Caffeine also inhibits phosphodiesterases in vitro, an effect characterized in pharmacology departments at University of Cambridge and Yale University, and alters intracellular calcium handling in models used by researchers at Johns Hopkins University School of Medicine. Its psychostimulant profile has been compared with substances evaluated by agencies such as the Food and Drug Administration and European Medicines Agency.

Metabolism and pharmacokinetics

Hepatic metabolism of caffeine is mediated primarily by cytochrome P450 enzymes (notably CYP1A2) characterized in studies at University of California, San Francisco and Karolinska Institute. Metabolites include paraxanthine, theobromine, and theophylline, compounds investigated at institutions like Massachusetts General Hospital and University of Toronto. Pharmacokinetic parameters such as oral bioavailability, volume of distribution, and elimination half-life have been reported in clinical pharmacology literature from Johns Hopkins, Vanderbilt University Medical Center, and Mayo Clinic, with variability due to genetic polymorphisms studied by groups at Broad Institute and Wellcome Trust. Factors affecting clearance include smoking status reviewed by researchers at Stanford University and pregnancy-related changes monitored at Imperial College London.

Health effects and risks

Acute effects on alertness and performance have been documented in randomized trials conducted at University of Michigan, University of Oxford, and Pennsylvania State University, while chronic consumption epidemiology has been reported in cohort studies by teams at Harvard T.H. Chan School of Public Health, Karolinska Institute, and University of Sydney. Observational links to cardiovascular outcomes have been examined by researchers at Framingham Heart Study and European Society of Cardiology, and associations with bone mineral density and pregnancy outcomes have been investigated by groups at World Health Organization and American College of Obstetricians and Gynecologists. Toxicology cases, including overdose and pediatric exposures, are managed by centers such as American Association of Poison Control Centers and documented in surveillance by Centers for Disease Control and Prevention. Interactions with medications metabolized by CYP1A2 have been reported in clinical guidelines from National Institute for Health and Care Excellence.

Uses and consumption patterns

Caffeine is used as a stimulant ingredient in beverages, foods, and pharmaceuticals produced by firms like PepsiCo, The Coca-Cola Company, Red Bull GmbH, and Mondelez International. Consumption patterns vary regionally, with high per-capita intake reported in Finland, Sweden, and Germany in surveys by the Organisation for Economic Co-operation and Development and Eurostat. Its role in sports performance enhancement has been evaluated in trials commissioned by organizations such as the International Olympic Committee and World Anti-Doping Agency. Cultural practices surrounding caffeinated drinks intersect with traditions observed in Italy, Turkey, and Japan, and trade flows are tracked by bodies such as the International Trade Centre.

Regulation and safety standards

Regulatory approaches to caffeinated products have been implemented by authorities including the U.S. Food and Drug Administration, European Food Safety Authority, and national agencies such as Health Canada and the Australian Therapeutic Goods Administration. Labeling requirements, maximum limits in beverages, and advisories for vulnerable populations have been issued following reviews by panels convened at institutions like World Health Organization and Food and Agriculture Organization. Workplace exposure and consumer safety standards intersect with guidance from Occupational Safety and Health Administration and European Commission directives. Public health campaigns addressing young-person consumption have been undertaken by organizations such as American Academy of Pediatrics and Public Health England.

Category:Alkaloids